Tiziana says intranasal drug shows potential to ease Long COVID “brain fog” [Yahoo! Finance]
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
Tiziana Reports Promising Data Showing Nasal Anti-CD3 May Improve Age-Related Cognitive Decline [TheStreet.com]
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging